SignatureFD’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117 Hold
26
﹤0.01% 3441
2026
Q1
$275 Sell
26
-26
-50% -$254 ﹤0.01% 3357
2025
Q4
$603 Hold
52
﹤0.01% 3200
2025
Q3
$1.27K Hold
52
﹤0.01% 3037
2025
Q2
$862 Hold
52
﹤0.01% 3044
2025
Q1
$954 Hold
52
﹤0.01% 3044
2024
Q4
$1.94K Hold
52
﹤0.01% 2882
2024
Q3
$1.68K Hold
52
﹤0.01% 2879
2024
Q2
$4.3K Hold
52
﹤0.01% 2568
2024
Q1
$7.59K Hold
52
﹤0.01% 2408
2023
Q4
$4.83K Hold
52
﹤0.01% 2506
2023
Q3
$8.65K Hold
52
﹤0.01% 2286
2023
Q2
$3.31K Hold
52
﹤0.01% 2642
2023
Q1
$1.78K Hold
52
﹤0.01% 2837
2022
Q4
$3.03K Sell
52
-13
-20% -$803 ﹤0.01% 2661
2022
Q3
$6K Buy
65
+7
+12% +$996 ﹤0.01% 2324
2022
Q2
$13K Buy
58
+5
+9% +$1.67K ﹤0.01% 1979
2022
Q1
$29K Hold
53
﹤0.01% 1644
2021
Q4
$35K Buy
53
+1
+2% +$764 ﹤0.01% 1508
2021
Q3
$43K Sell
52
-1
-2% -$1.01K ﹤0.01% 1381
2021
Q2
$67K Buy
53
+6
+13% +$6.77K ﹤0.01% 1130
2021
Q1
$51K Hold
47
﹤0.01% 1161
2020
Q4
$67K Sell
47
-26
-36% -$27.7K ﹤0.01% 947
2020
Q3
$52K Hold
73
﹤0.01% 962
2020
Q2
$51K Buy
73
+7
+11% +$4.04K ﹤0.01% 938
2020
Q1
$23K Buy
+66
New +$46.7K ﹤0.01% 1177

Other funds holding CDLX

SignatureFD's CDLX Position: Q2 2026 in Review

SignatureFD held its Cardlytics (CDLX) position steady in Q2 2026 at 26 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #3441.

SignatureFD first reported a position in CDLX in Q1 2020 and has held it in 26 quarters since. The position peaked at $67K in Q2 2021. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • SignatureFD held 26 shares of Cardlytics worth $117 as of Q2 2026.
  • SignatureFD left its Cardlytics share count unchanged in Q2 2026.
  • Cardlytics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3441 holding.
  • SignatureFD first reported a position in Cardlytics in Q1 2020 and has held it in 26 quarters since.
  • SignatureFD's Cardlytics position peaked at $67K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.